Improvement of intestinal flora: accompany with the antihypertensive effect of electroacupuncture on stage 1 hypertension

Abstract

Background Increasing evidence have indicated the relationship between intestinal dysbiosis and hypertension. We aimed to evaluate the effect of the electroacupuncture (EA) on intestinal microbiota in patients with stage 1 hypertension. Methods 93 hypertensive patients and 15 healthy subjects were enrolled in this study. Applying a highly accurate oscillometric device to evaluate the antihypertensive effect of EA. 16S rRNA sequencing was used to profile stool microbial communities from Healthy group, Before treatment (BT) group and After treatment (AT) group, and various multivariate analysis approaches were used to assess diversity, composition and abundance of intestinal microbiota. Results In this study, EA significantly decreased the blood pressure (BP) of hypertensive patients. Higher abundance of Firmicutes and lower Bacteroidetes abundance were observed in the BT group compared to the Healthy group. And EA treatment significantly decreased the Firmicutes/Bacteroidetes ratio compared to the BT group. Moreover, at the genus level, there was an increased abundance of Escherichia-Shigella in patients with hypertension, while Blautia were decreased, and EA reversed these changes. Conclusions Our study indicates that EA can effectively lower BP and improve the structure of intestinal microbiota which are correlate with the alteration of blood pressure by electroacupuncture. Trial registration: Clinicaltrial.gov, NCT01701726. Registered 5 October 2012, https://clinicaltrials.gov/ct2/show/study/NCT01701726

Specific Alterations of Gut Microbiota in Chinese Patients with Hypertension: A Systematic Review and Meta-Analysis

“…Table 4). Of these assessments, seven (7/13) [14, 30, 34, 36, 37, 40, 41] provided data and were included in meta-analyses. We used bacterial diversity indexes (Shannon and Simpson indexes, Fig.…”

“…Ten (10/16) studies [14, 24, 30, 33, 34, 37, 39-41] measured the β-diversity of gut microbiota mainly using principal coordinate analysis or principal component analysis. Consistent differences between hypertensive and control were reported by eight (8/10) studies [14, 24, 30, 33, 34, 36, 40, 41].…”

Perinatal Resveratrol Therapy to Dioxin-Exposed Dams Prevents the Programming of Hypertension in Adult Rat Offspring

“…Our results provide important information on how resveratrol alters gut microbes and restores the balance of TH17/Treg to prevent the programming of hypertension. Additionally, low level of genus Lachnoclostridium but high abundance of Ruminiclostridium has been identified in hypertensive patients [ 35 , 36 ]. According to our data, resveratrol treatment increased Lachnoclostridium and decreased Ruminiclostridium_9 .…”

Resveratrol Butyrate Ester Protects Adenine-Treated Rats against Hypertension and Kidney Disease by Regulating the Gut–Kidney Axis

“…Interestingly, the data in this work showed that resveratrol protects against adenine-induced hypertension and kidney damage, which coincides with an abundance of the genera Parabacteroides , Blautia , and Alistipes. Given that the abundance of the genera Alistipes and Blautia was inversely associated with BP [ 29 , 30 ], that resveratrol increased the abundance of the genera Parabacteroides , and Alistipes was associated with protection against kidney damage in a diabetic nephropathy model [ 31 ], it is possible that resveratrol can influence these microbes towards renoprotection and have a BP-lowering benefit.…”